Spironolactone
Product Images NDC 53002-4721

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 53002-4721). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Spironolactone 01)

FDA Label Image

Figure 1 (Spironolactone 02)

Figure 1 (Spironolactone 02)
This text appears to be a report or analysis involving the medication "Spronolctone" and a placebo. There is mention of probability and a statistical significance (Log-rank p: <0.001). The text also includes a timeline with months labeled from 4 to 48. The specific details or context of the analysis are not provided.*
FDA Label Image

Figure 2 (Spironolactone 03)

FDA Label Image

Label Image (Lbl530024721)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.